S.-H. Son et al. / Tetrahedron Letters 49 (2008) 5289–5292
5291
Supplementary data
OR
O
O
Ph
O
O
Supplementary data associated with this article can be found, in
O
RO
i
O
3 + 4
O
OMe
O
References and notes
13 : R = Bz
5 : R = H
ii
1. (a) Dhir, V. K.; Dodd, C. E. Appl. Environ. Microbiol. 1995, 61, 1731–1738; (b)
Jones, K.; Bradshaw, S. B. J. Appl. Bacteriol. 1996, 80, 458–464.
2. Austin, J. W.; Sanders, G.; Kay, W. W.; Collinson, S. K. FEMS Microbiol. Lett. 1998,
162, 295–301.
3. (a) Carpentier, B.; Cerf, O. J. Appl. Bacteriol. 1993, 75, 499–511; (b) Austin, J. W.;
Bergeron, G. J. Dairy Res. 1995, 62, 509–519.
OR
O
O
O
Ph
O
iii
O
4. Snyder, D. S.; Gibson, D.; Heiss, C.; Kay, W.; Azadi, P. Carbohydr. Res. 2006, 341,
2388–2397.
O
O
BnO
5. (a) Appleton, J. A.; Schain, L. R.; McGregor, D. D. Immunology 1988, 65, 487–492;
(b) Denkers, E. Y.; Hayes, C. E.; Wassom, D. L. Exp. Parasitol. 1991, 72, 403–410;
(c) Nitz, M.; Bundle, D. R. J. Org. Chem. 2000, 65, 3064–3073; (d) Hirooka, M.;
Yoshimura, A.; Saito, I.; Ikawa, F.; Uemoto, Y.; Koto, S.; Takabatake, A.;
Taniguchi, A.; Shinoda, Y.; Morinaga, A. Bull. Chem. Soc. Jpn. 2003, 76, 1409–
1421. and references cited therein.
O
OBz
iv
OMe
14 : R = H
15 : R = Ac
6. Davis, B.; Brandstetter, T. W.; Smith, C.; Hackett, L.; Winchester, B. G.; Fleet, G.
W. J. Tetrahedron Lett. 1995, 36, 7505–7510.
OBn
O
BnO
BnO
Ph
7. (a) Matsui, H.; Furukawa, J.; Awano, T.; Nishi, N.; Sakairi, N. Chem. Lett. 2000,
326–327; (b) Matsuoka, K.; Onaga, T.; Mori, T.; Sakamoto, J.-I.; Koyama, T.;
Sakairi, N.; Hatano, K.; Terunuma, D. Tetrahedron Lett. 2004, 45, 9383–9386; (c)
Son, S.-H.; Tano, C.; Furukawa, J.-i.; Furuike, T.; Sakairi, N. Org. Biomol. Chem.
2008, 6, 1441–1449.
BnO
O
O
O
v
O
O
8. Oikawa, M.; Liu, W.-C.; Nakai, Y.; Koshida, S.; Fukase, K.; Kusumoto, S. Synlett
1996, 1179–1180.
O
O
9. Van den Bos, L. J.; Boltje, T. J.; Provoost, T.; Mazurek, J.; Overkleeft, H. S.; van der
Marel, G. A. Tetrahedron Lett. 2007, 48, 2697–2700.
10. (a) Rasmussen, J. R. J. Org. Chem. 1980, 45, 2725–2727; (b) Bart, R.; Pavol, K.
Synthesis 2004, 2505–2508; (c) Turek, D.; Sundgren, A.; Lahmann, M.;
Oscarson, S. Org. Biomol. Chem. 2006, 4, 1236–1241.
O
O
BnO
O
OBz
OMe
16
11. Veeneman, G. H.; van Leeuwen, S. H.; van Boom, J. H. Tetrahedron Lett. 1990, 31,
1331–1334.
12. Representative 1H NMR, and other physical data of compounds 13, 5, 14, 15, 16,
and 2.
vi
2
Compound 13: ½a D20:0
ꢂ
ꢁ94.3 (c 1.00, CHCl3); 1H NMR (300 MHz, CDCl3): d 5.81
(dd, 1H, J3 ;4 ¼ 3:4 Hz, H-30), 5.65 (dd, 1H, J2 ;3 ¼ 3:5 Hz, H-20), 5.12 (s, 1H,
H-10), 4.88 (s, 1H, H-1), 1.37 (d, 3H, J = 6.1 Hz, H-6); HRMS (FAB) calcd for
0
0
0
0
Scheme 3. Construction of tetrasaccharide 2 by assembly of dodecyl thioglyco-
sides. Reagents and conditions: (i) NIS, TfOH, CH2Cl2, MS4 Å, ꢁ20 °C to 0 °C, 30 min,
90%; (ii) NaOMe/MeOH–CH2Cl2, rt, 3 h, 96%; (iii) 6, NIS, TfOH, CH2Cl2, MS4 Å,
ꢁ40 °C, 30 min, 92%; (iv) Ac2O, pyridine; (v) 7, BSP, Tf2O, DTBM, CH2Cl2, MS4 Å,
ꢁ78 °C, 72%; (vi) (a) 80% AcOH in H2O, 50 °C, 24 h; (b) NaOMe/MeOH, rt, 6 h; (c) Pd/
C, MeOH–H2O–AcOH, H2, rt, 24 h, 76% over three steps.
C
37H41O12 [M+H]+: 677.2593; found, 677.2592.
Compound 5: ½a D20:0
ꢂ
ꢁ43.9 (c 1.00, CHCl3); 1H NMR (300 MHz, CDCl3): d 4.90 (s,
1H, H-10), 4.85 (s, 1H, H-1), 1.27 (d, 1H, J = 6.3 Hz, H-6); HRMS (FAB) calcd for
C
23H33O10 [M+H]+: 469.2068; found, 469.2075.
Compound 14: ½a D21:8
ꢂ
+38.6 (c 1.00, CHCl3); 1H NMR (600 MHz, CDCl3): d 8.01–
7.18 (m, 15H, CHarom), 5.59 (s, 1H, PhCH), 5.31 (s, 1H, H-200), 5.28 (s, 1H, H-100),
4.95 (s, 1H, H-10), 4.84 (s, 1H, H-1), 4.62 (d, 1H, J = 11.0 Hz, PhCH2), 4.47 (d, 1H,
J = 11.6 Hz, PhCH2), 4.31–4.28 (m, 1H, H-60a), 4.25–4.18 (m, 1H, H-60b), 4.16–
4.02 (m, 5H, H-2, 3, 20, 30, 40), 3.89–3.85 (m, 1H, H-500), 3.84–3.78 (m, 1H, H-50),
3.69–3.62 (m, 1H, H-5), 3.49–3.44 (m, 1H, H-400), 3.58–3.42 (m, 1H, H-4), 3.36
(s, 3H, OMe), 2.53 (s, 1H, OH), 2.40–2.34 (m, 1H, H-300), 2.04–1.96 (m, 1H, H-300),
1.52 (s, 3H, CH3), 1.35 (d, 3H, J = 6.6 Hz, H-600), 1.33 (s, 3H, CH3), 1.27 (d, 3H,
J = 6.6 Hz, H-6); HRMS (FAB) calcd for C43H53O14 [M+H]+: 793.3430; found,
793.3437.
thiogalactosyl donors using sulfonium triflate per-activation
procedure.14
Finally, global deprotection of 16 was successfully carried out
by a three-step procedure that involved the hydrolysis of the acetal
protecting groups by treatment with aqueous AcOH, transesterifi-
cation of the O-benzoyl groups with sodium methoxide in metha-
nol, and catalytic hydrogenolysis over Pd/C to remove the O-benzyl
groups. The unprotected tetrasaccharide12 2 thus obtained was
characterized spectroscopic analyses. Representative 1H and 13C
NMR chemical shift data of the synthetic tetrasaccharide 2 is in
excellent agreement with the reported data4 of the natural poly-
saccharide 1.
In conclusion, total synthesis of a tetrasaccharide repeating unit
of O-antigenic polysaccharide of S. enteritidis was achieved by
assembly of dodecyl thioglycosyl donors. Our finding such as reg-
ioselective and sequential glycosylation 2,3-positions of core man-
nose residue would make it possible to provide easily various
oligosaccharides analogous of 2, which are useful substrates for
biological examinations toward its infection control.
Compound 15: 1H NMR (300 MHz, CDCl3): d 7.97–7.22 (m, 15H, CHarom), 5.63
(s, 1H, PhCH), 5.26 (br d, 1H, H-200), 5.21 (dd, 1H, J2 ;3 ¼ 3:5 Hz, H-20), 5.16 (s,
0
0
1H, H-100), 4.91 (d, 1H, J1 ;2 ¼ 1:2 Hz, H-10), 4.85 (s, 1H, H-1), 4.62 (d, 1H,
0
0
0
0
J = 11.6 Hz, PhCH2), 4.47 (d, 1H, J = 11.6 Hz, PhCH2), 4.34 (dd, 1H, J3 ;4 ¼ 9:5 Hz,
H-30), 4.27 (dd, 1H, J5 ;6 b ¼ 4:2 Hz, H-60b), 4.18–4.06 (m, 4H, H-2, 3, 40, 60a),
3.87–3.76 (m, 2H, H-50, 500), 3.70–3.61 (m, 1H, H-5), 3.55–3.33 (m, 2H, H-4, 400),
3.35 (s, 3H, OMe), 2.33–2.26 (m, 1H, H-300), 2.18 (s, 3H, acetyl), 2.08–1.92 (m,
1H, H-300), 1.51 (s, 3H, CH3), 1.33 (s, 3H, CH3), 1.32 (d, 3H, J = 6.3 Hz, H-600), 1.31
(d, 3H, J = 6.3 Hz, H-6); 13C NMR (150.9 MHz, CDCl3): d 170.3, 165.4, 138.2,
137.3, 133.2, 130.1, 129.8, 128.7, 128.4, 128.4, 128.1, 127.9, 127.7, 126.0, 109.2,
0
0
101.3, 99.0 (JC1 ;H1 ¼ 175:9 Hz, C-10), 97.8 (JC1,H1 = 170.0 Hz, C-1), 97.7
0
0
(JC1
¼ 172:9 Hz, C-100), 81.2, 78.7, 76.7, 76.0, 74.9, 72.1, 71.4, 71.0, 70.8,
00 ;H100
68.8, 68.7, 64.6, 63.8, 54.9, 29.3, 28.1, 26.4, 21.0, 18.2, 17.4.
Compound 16: ½a D21:0
ꢂ
+34.1 (c 1.00, CHCl3); 1H NMR (600 MHz, CDCl3): d 5.62
(d, 1H, J1
¼ 3:8 Hz, H-1000), 5.29 (s, 1H, H-100), 4.93 (s, 1H, H-10), 4.83 (s, 1H,
000 ;2000
H-1), 4.39 (dd, 1H, J3 ;4 ¼ 10:4 Hz, H-30), 4.17 (dd, 1H, J2 ;3 ¼ 5:0 Hz, H-20),
0
0
0
0
2.29–2.23 (m, 1H, H-300), 1.90–1.84 (m, 1H, H-300), 1.32 (d, 3H, J = 6.1 Hz, H-600),
1.18 (d, 3H, J = 6.1 Hz, H-6); HRMS (FAB) calcd for
C
77H87O19 [M+H]+:
1315.5836; found, 1315.5829.
Compound 2: 1H NMR (300 MHz, D2O, 333 K): (selected data) d 5.25 (d, 1H,
J1 ;2 ¼ 1:5 Hz, H-10), 5.21 (d, 1H, J1
¼ 3:7 Hz, H-1000), 4.90 (br d, 1H, H-1),4.70
0
0
000 ;2000
00 ;200
(d, 1H, J1
¼ 1:4 Hz, H-100), 4.18–3.52 (m, 29H), 3.40 (s, 3H, OMe), 2.08–2.01
(m, 1H, H-300), 1.90–1.78 (m, 1H, H-300), 1.34 (d, 3H, J5,6 = 6.4 Hz, H-6), 1.28 (d,
Acknowledgment
3H, J5 ;6 ¼ 6:2 Hz, H-60); 13C NMR (75 MHz, D2O): d 104.1, 104.0, 103.5, 102.5,
84.4, 81.8, 80.1, 76.3, 74.3, 73.2, 73.1, 72.1, 72.1, 71.5, 70.2, 70.2, 70.0, 69.1,
64.0, 63.3, 57.6, 19.9, 19.6; HRMS (ESI) calcd for C25H44O18 [MꢁH+]ꢁ: 631.2455;
found, 631.2452.
0
0
We would like to thank Ms. A. Meada (Center for Instrumental
Analysis, Hokkaido University) for elemental analyses.